- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Chronic Lung Disease and COVID-19: ALA Answers Patient Questions
Does COVID-19 cause lasting consequences in patients with chronic lung disease? The answer to this and other common FAQs from these patients provided by the American Lung Association.
Patients living with chronic lung disease are at significantly greater risk for severe disease and complications if they become infected with COVID-19, although they are not thought to be at greater risk for contracting the disease. The American Lung Association (ALA) offers a webinar every Monday for patients that features ALA chief medical officer Albert A. Rizzo, MD. Dr Rizzo provides updates on the evolving COVID-19 environment and recommendations for people with chronic lung disease and their caregivers.The short slide show below features questions frequently asked by patients with lung disease and Dr Rizzo's answers. You may be asked these or similar questions by your own lung disease patients. Provide them with the link to the webinar registration page using the link in the caption to the final slide.
